These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
468 related articles for article (PubMed ID: 22237887)
1. Immune suppression in the tumor microenvironment: a role for dendritic cell-mediated tolerization of T cells. Hurwitz AA; Watkins SK Cancer Immunol Immunother; 2012 Feb; 61(2):289-293. PubMed ID: 22237887 [TBL] [Abstract][Full Text] [Related]
2. Role of Tumor-Mediated Dendritic Cell Tolerization in Immune Evasion. DeVito NC; Plebanek MP; Theivanthiran B; Hanks BA Front Immunol; 2019; 10():2876. PubMed ID: 31921140 [TBL] [Abstract][Full Text] [Related]
3. Dendritic Cells and CD8 T Cell Immunity in Tumor Microenvironment. Fu C; Jiang A Front Immunol; 2018; 9():3059. PubMed ID: 30619378 [TBL] [Abstract][Full Text] [Related]
4. CCL21 Programs Immune Activity in Tumor Microenvironment. Sharma S; Kadam P; Dubinett S Adv Exp Med Biol; 2020; 1231():67-78. PubMed ID: 32060847 [TBL] [Abstract][Full Text] [Related]
5. Intratumoral CpG-B Promotes Antitumoral Neutrophil, cDC, and T-cell Cooperation without Reprograming Tolerogenic pDC. Humbert M; Guery L; Brighouse D; Lemeille S; Hugues S Cancer Res; 2018 Jun; 78(12):3280-3292. PubMed ID: 29588348 [TBL] [Abstract][Full Text] [Related]
6. [Immune system and tumors]. Terme M; Tanchot C Ann Pathol; 2017 Feb; 37(1):11-17. PubMed ID: 28159405 [TBL] [Abstract][Full Text] [Related]
7. T-cell death and cancer immune tolerance. Lu B; Finn OJ Cell Death Differ; 2008 Jan; 15(1):70-9. PubMed ID: 18007660 [TBL] [Abstract][Full Text] [Related]
12. Dendritic Cells and Cancer Immunity. Gardner A; Ruffell B Trends Immunol; 2016 Dec; 37(12):855-865. PubMed ID: 27793569 [TBL] [Abstract][Full Text] [Related]
13. Breaking immunotolerance of tumors: a new perspective for dendritic cell therapy. Rolinski J; Hus I J Immunotoxicol; 2014 Oct; 11(4):311-8. PubMed ID: 24495309 [TBL] [Abstract][Full Text] [Related]
14. Signaling defects in anti-tumor T cells. Frey AB; Monu N Immunol Rev; 2008 Apr; 222():192-205. PubMed ID: 18364003 [TBL] [Abstract][Full Text] [Related]
15. Immune Cell-Derived Exosomes in the Cancer-Immunity Cycle. Yan W; Jiang S Trends Cancer; 2020 Jun; 6(6):506-517. PubMed ID: 32460004 [TBL] [Abstract][Full Text] [Related]
16. A stressful microenvironment: opposing effects of the endoplasmic reticulum stress response in the suppression and enhancement of adaptive tumor immunity. Rausch MP; Sertil AR Int Rev Immunol; 2015 Mar; 34(2):104-22. PubMed ID: 25774773 [TBL] [Abstract][Full Text] [Related]
17. Anti-tumor immunity: myeloid leukocytes control the immune landscape. Rutkowski MR; Stephen TL; Conejo-Garcia JR Cell Immunol; 2012; 278(1-2):21-6. PubMed ID: 23121972 [TBL] [Abstract][Full Text] [Related]
18. Dendritic cells in the tumor microenvironment: prognostic and theranostic impact. Verneau J; Sautés-Fridman C; Sun CM Semin Immunol; 2020 Apr; 48():101410. PubMed ID: 33011065 [TBL] [Abstract][Full Text] [Related]
20. Significance of regional draining lymph nodes in the development of tumor immunity: implications for cancer immunotherapy. Zheng R; Kjaergaard J; Lee WT; Cohen PA; Shu S Cancer Treat Res; 2007; 135():223-37. PubMed ID: 17953420 [No Abstract] [Full Text] [Related] [Next] [New Search]